Fierce Pharma

An update on the pharma industry’s reshoring effort

Apr 3, 2026 9:47am

Where does pharma’s reshoring push stand today, and what comes next? Reshoring Institute Executive Director Rosemary Coates explains the industry’s unique advantage and the hurdles still in the way.

Biopharma R&D pipeline shrinks for 1st time in 30 years: report

Apr 3, 2026 3:44am

The number of drugs in development has fallen for the first time since the mid-1990s, according to a Citeline report. While methodological changes may have affected the result, the dip highlights a period when drugmakers have trimmed their pipelines and cut the number of new projects starting development.

Fierce Pharma Asia—Trump’s 100% drug tariff; Takeda layoffs; Lilly, Insilico's AI deal

Apr 2, 2026 6:41pm

The U.S. will impose a 100% tariff on drug imports with some exceptions. Takeda plans to cut 634 jobs in the U.S. as part of its $1.26 billion savings plan. Eli Lilly deepened its relationship with AI drug-discovery expert Insilico Medicine through a deal worth up to $2.75 billion. And more.

Trump slaps 100% duties on imported drugs but leaves plenty of exceptions

Apr 2, 2026 4:39pm

The president has rolled out a 100% tariff rate on patented pharmaceutical products and ingredients following a "Section 232" investigation, according to a White House fact sheet.

UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments

Apr 2, 2026 3:03pm

The U.K.'s end of the deal requires it to spend more on drugs through its National Health Service, which it is implementing through a higher cost-effectiveness threshold for its National Institute for Health and Care Excellence (NICE).

BioNTech telegraphs closure of Singapore vaccine facility amid efforts to 'align capacity'

Apr 2, 2026 2:29pm

BioNTech is turning out the lights at the Singapore plant it purchased from Novartis at the height of the COVID-19 outbreak, reflecting a sharp reversal in the mRNA specialist’s trajectory since the pandemic’s end.

Rising Stars: The Trade Desk's Elizabeth Keenan finds the rhythm in music and media

Apr 2, 2026 1:18pm

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Keenan discussed how she landed on the tech side of pharma marketing, how lived experiences can influence campaigns, and what spinning tunes and serving up ads have in common.

Trump eyes 100% tariff rate for companies that have not struck MFN deals: Bloomberg

Apr 2, 2026 11:13am

A year after revealing his “Liberation Day” trade policy initiatives, U.S. President Donald Trump is set to announce tariffs of 100% on some pharmaceutical products imported from outside the country, Bloomberg reports, citing unidentified sources who know about the plan. Companies that have struck MFN deals would be exempt from the levies.

Poland, Romania must pay Pfizer $2.2B in fight over contested COVID vaccine doses: Belgian court

Apr 2, 2026 11:03am

A Belgian court ordered Poland and Romania to pay Pfizer for COVID vaccines after the countries had attempted to get out of Europe's massive vaccine procurement deal.

Lilly's obesity pill Foundayo gains early blockbuster forecast as analysts float 5M+ prescriptions in 2026

Apr 2, 2026 11:13am

As the battle for the weight-loss market expands to oral drugs, analysts are already predicting a blockbuster rollout of Lilly's Foundayo, while Novo is aggressively touting superior weight-loss data for its Wegovy pill to protect its first-mover advantage.

Another AstraZeneca Emerald glimmers as Imfinzi, Imjudo delay liver cancer progression

Apr 2, 2026 9:49am

Another green light appears increasingly within reach for AstraZeneca’s Emerald program after a combo regimen featuring the company’s immunotherapy duo, Imfinzi and Imjudo, showed a progression-free survival benefit in patients with locoregional liver cancer.

Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model

Apr 2, 2026 4:46am

Six years after signing a U.S. marketing partnership with Hikma Pharma for its seasonal allergy spray Ryaltris, India’s Glenmark is now going it alone.

German CDMO Adragos buys French sterile injectables plant from Sanofi

Apr 2, 2026 7:58am

Adragos Pharma, a German CDMO, snapped up one of Europe’s largest sterile injectables production plants for an undisclosed price from Sanofi.

Bayer rejigs marketing claims after recommendation from US advertising body

Apr 2, 2026 4:04am

Bayer has been asked to rein in claims that its One A Day Men’s Pre-Conception Health Complete Multivitamin can help boost male fertility after a rival company challenged the German pharma’s marketing push.

Lilly answers Novo's GLP-1 pill with highly anticipated FDA nod for Foundayo

Apr 1, 2026 12:12pm

The FDA has approved Lilly’s GLP-1 receptor agonist pill as the first new molecular entity cleared under the regulator’s controversial Commissioner's National Priority Voucher program.

Regulatory tracker: Vertex secures broader FDA labels for cystic fibrosis meds Alyftrek, Trikafta

Jan 2, 2026 8:07am

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Novo's Wegovy nets cardio nod from UK cost gatekeeper, adding 1M+ eligible patients

Apr 1, 2026 9:18am

The National Institute for Health and Care Excellence, which serves as the U.K.’s drug price regulator, has given the green light to Wegovy (semaglutide) as a weekly injection to prevent heart attacks and strokes. The endorsement is separate from Wegovy’s primary use as a weight loss medication.

‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1

Apr 1, 2026 3:50am

Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the figures.

FDA extends review of Orca Bio’s novel cell therapy for blood cancers

Mar 30, 2026 9:48pm

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6 after the company submitted additional CMC-related data.

Evotec hires exec with AI experience to lead rebooted commercial team

Apr 1, 2026 5:40am

Evotec has appointed Ashiq Khan, Ph.D., as chief commercial officer, putting an executive with robotics and artificial intelligence experience in charge of a unit that is central to the company’s recently unveiled transformation plan.

#FierceMadness: Your Final Four revealed for the 2026 Drug Name Tournament—VOTE NOW

Mar 17, 2026 1:34pm

It’s time once again for Fierce Pharma Marketing’s annual #FierceMadness tournament. This time around, we're watching 64 newly minted drug names go head to head.

FDA flags serious liver injury cases, 8 deaths with ‘reasonable’ link to Amgen's Tavneos

Mar 31, 2026 2:47pm

The agency identified 76 cases of drug-induced liver injury in patients who used Amgen's Tavneos, including eight deaths.

Novo Nordisk cuts 400 roles at troubled Bloomington site

Mar 31, 2026 2:35pm

Amid a major corporate overhaul, Novo Nordisk is pruning the ranks at its Bloomington, Indiana, production facility, which contributes to the blockbuster GLP-1 medications Ozempic and Wegovy.

Iterum initiates wind-down after failure to offload antibiotic with sluggish sales

Mar 31, 2026 2:00pm

Irish antibiotic specialist Iterum Therapeutics has started winding down its operations, citing limited cash amid the expensive commercialization of its only approved product, Orlynvah.

API supplier BASF raises prices up to 20% in response to rising energy, raw material costs

Mar 31, 2026 10:33am

BASF Pharma Solutions will raise its prices by up to 20% for its excipients and some of its active pharmaceutical ingredients, effective immediately.